my country's pharmaceutical export volume has grown steadily, and may reach a new high in 2021

In recent years, driven by a series of national support policies, the strategic position of my country's pharmaceutical industry has gradually emerged.
While the industry has continued to grow, the export of pharmaceutical materials and drugs has also achieved a certain degree of growth.
Statistics show that in 2020, China's export volume of medical materials and medicines was 1,14371 tons, an increase of 7.
5% year-on-year; the export value was 2,303,311 million US dollars, an increase of 26.
6%.
In addition, according to monthly data, the export value of Chinese medicinal materials and medicines from January to February 2020 was US$2,548,870 thousand; during the period from March to December, the export value of Chinese medicinal materials and medicines peaked in December at US$2,947,514 thousand.

 

On the whole, the increase in demand in the pharmaceutical market in 2020 will drive my country's pharmaceutical exports to achieve another growth.
The industry predicts that my country's supply-side structural reforms have achieved initial results, and new development momentum is being formed.
With the unique differentiated competitive advantages of China's pharmaceutical market being formed, the export volume in 2021 will continue to grow steadily.

 

In fact, since the beginning of this year, news of growth in exports of medicinal materials and medicines has been reported in many places.
According to statistics from Beijing Customs, in the first February of 2021, the import and export of Beijing area was RMB 425.
67 billion, an increase of 0.
7% year-on-year (the same below).
Among them, imports were 345.
71 billion yuan, a decrease of 0.
1%; exports were 79.
96 billion yuan, an increase of 4.
2%.
In addition, the export of medical materials and drugs was 6.
52 billion yuan, an increase of 12 times;
 

In addition, according to Zhengzhou Customs, in January, Henan Province exported 188.
3 tons of 3s ease 0s;text-decoration-line:none;">Chinese medicinal materials with a value of 4.
633 million yuan, a year-on-year increase of 70.
3% and 75.
4% respectively.
It is understood that in recent years, the Chinese herbal medicine industry in Henan Province has continued to expand exports.
In 2020, Zhengzhou Customs will export a total of 1389.
8 tons of various Chinese medicinal materials under quarantine supervision, a year-on-year increase of 2 times.
According to industry analysis, this is mainly due to the fact that, in order to promote the continuous expansion of exports of the Chinese medicinal materials industry in Henan Province, Zhengzhou Customs has conducted in-depth investigations on export enterprises in the jurisdiction, and "checks the pulse" one by one, focusing on information channels, plant epidemic prevention, quality management, and customs clearance timeliness.
"Prescribe the right medicine" for the difficulties that exist in this regard, and prescribe multiple curative "prescriptions".

 

  However, it is worth noting that according to my country's pharmaceutical export data in 2020, although my country's pharmaceutical industry is forming a unique differentiated competitive advantage in the market, it has to be admitted that there are still certain differences between my country's pharmaceutical market and overseas markets.
It is understood that China's local pharmaceutical R&D and innovation level is still in the growth stage.
Therefore, the total export volume of innovative drugs is relatively small.
It is understood that in 2018, China's large-scale preparation companies had an average annual export volume of less than 100 million.
While 54% of exports are to Asia and Africa, Europe and the United States only account for 29%.

 

  Generally speaking, to become a big manufacturing country, the domestic pharmaceutical industry still has a long way to go, and the domestic pharmaceutical industry also needs to rely on the continuous introduction of favorable national policies to promote more orderly, higher technological content, environmental protection, The development of resource conservation, increased value-added, and downstream extension will be more conducive to the continuous optimization and upgrading of the export structure, and the continuous expansion of the export market share of medical materials and medicines.